154
Views
6
CrossRef citations to date
0
Altmetric
Articles

Molecular dynamics simulation study of Glycine tip-functionalisation of single-walled carbon nanotubes as emerging nanovectors for the delivery of anticancer drugs

, , &
Pages 111-120 | Received 23 Dec 2017, Accepted 02 Oct 2019, Published online: 31 Oct 2019
 

ABSTRACT

In this work, molecular dynamics (MD) simulations have been performed to explore dynamic properties of three anticancer drugs including Exemestane (EXE), Letrozole (LTZ) and Fulvestrant (FLV) interacting with single-walled carbon nanotubes (SWCNTs) as drug delivery systems in a biological environment. Furthermore, the effect of functionalisation of SWCNTs with Glycine (Gly) group on the drug adsorption process is investigated. The MD simulation results show that among three investigated drugs, FLV with high hydrophobic characteristic exhibits the strongest affinity for hydrophobic SWCNT (16, 8) in terms of the binding free (ΔGbin) amount energy. Moreover, strong binding of FLV drug molecules on the functionalised single-walled carbon nanotube (f-SWCNT) with (16, 0) chirality is facilitated by more active sites available for hydrogen bond (HB) formation between drug molecules and the functional groups of SWCNT. Because of more number of HBs in the simulation system, there are more numbers of hydrophilic interactions between the adsorbed drug molecules and the functional groups of the nanotube.

Disclosure statement

No potential conflict of interest was reported by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.